Net Cash Provided by (Used in) Operating Activities |
-178K |
USD |
-47.5% |
Sep 30, 2023 |
Q3 2023 |
Net Cash Provided by (Used in) Financing Activities |
108K |
USD |
-67.1% |
Sep 30, 2023 |
Q3 2023 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Sep 30, 2023 |
Q3 2023 |
Common Stock, Shares Authorized |
750M |
shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Common Stock, Shares, Issued |
114M |
shares |
+1.71% |
Dec 31, 2023 |
Q4 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-61.3K |
USD |
|
Jun 30, 2022 |
2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
113K |
USD |
-67.2% |
Dec 31, 2023 |
Q4 2023 |
Deferred Income Tax Expense (Benefit) |
-75.9K |
USD |
|
Sep 30, 2023 |
Q3 2023 |
Preferred Stock, Shares Issued |
5M |
shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Additional Paid in Capital |
1.52M |
USD |
+13.1% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Outstanding |
5M |
shares |
0% |
Dec 31, 2023 |
Q4 2023 |
Depreciation, Depletion and Amortization |
6.45K |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
218K |
USD |
+73.4% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Dec 31, 2023 |
Q4 2023 |